Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf nausea or vomiting is hitting you after dark on Mounjaro, you're not imagining a pattern. Evening sickness is one of the more commonly reported timing quirks with tirzepatide, and it has straightforward biological reasons behind it. Mounjaro slows gastric emptying as part of how it works — meals linger longer in the stomach than usual, and if dinner sits heavily, the discomfort often peaks a few hours later. That said, nausea on Mounjaro is usually most pronounced in the first weeks of treatment or after a dose increase, and many people find it eases considerably once their body adjusts. These are prescription-only medicines, so any persistent or distressing symptoms are worth raising with your prescriber rather than managing alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you took your Mounjaro pen mid-week, had a normal enough dinner, then found yourself staring at the ceiling at 11pm with a churning stomach. It's a scenario that comes up regularly, and the mechanism is well understood. Tirzepatide activates both GIP and GLP-1 receptors, which slows the rate at which the stomach empties. That's exactly how it reduces appetite during the day, food stays with you longer, so you feel full sooner. The downside is that a larger evening meal can sit in the stomach for far longer than it would without the medicine, and the resulting discomfort tends to surface late in the evening or during the night when you're horizontal and distracted by nothing else.
Lying down also reduces the mechanical help gravity gives digestion. When you're upright, the stomach drains downward more easily; flat in bed, that process slows further. If you've also had anything particularly fatty, rich or high in refined sugar, those foods are among the slowest to clear even at baseline, add tirzepatide's gastric-slowing effect on top and the combination can tip into genuine nausea. The NHS tirzepatide patient page lists nausea, vomiting and indigestion as recognised side effects, most common at the start of treatment or after a dose step-up.
None of this means the medicine isn't working, quite the opposite. The gastric slowing that causes the discomfort is part of the same mechanism producing the weight-loss benefit. For most people, the timing and intensity of nausea shifts as the body adjusts over the first few weeks at each dose, and our guide to Mounjaro sickness explains in more detail why these symptoms follow the pattern they do and what typically helps.
Timing matters more than many people realise. Mounjaro is injected once a week and reaches peak plasma concentration roughly 24–72 hours after the dose for most people. If you inject on a Friday evening and feel roughest on Saturday night, that fits the pharmacokinetic profile. Some people find that shifting their injection day so that the peak falls on a quieter day (or a day when they can eat lightly and rest) takes the edge off noticeably.
There is no single right time of week to inject; the SmPC does not specify one. What matters is consistency: the same day each week, adjusted to suit your schedule. If Saturday night nausea is disrupting sleep, injecting on Sunday morning instead shifts the peak toward Tuesday, when you might be at work and naturally eating more carefully anyway. This is the sort of practical adjustment worth discussing with your prescriber or the aftercare team, it costs nothing to try and can make a real difference to how manageable those first days of each dose feel. Our guide to Mounjaro nausea at night explores the timing question in more detail if the pattern is specifically around nausea rather than vomiting.
People who are also curious about night-time diarrhoea on Mounjaro sometimes find both symptoms cluster around the same post-injection window, useful to notice if you're logging how you feel week to week.
The most consistent feedback from people managing tirzepatide nausea is that evening meal size and composition matter enormously. A large, fatty meal close to bedtime is the combination most likely to cause trouble. Smaller portions (enough to feel satisfied rather than full) clear more reliably. Eating earlier in the evening gives the stomach a longer window before you lie down, which helps more than almost anything else.
Fatty and fried foods, very spicy dishes, carbonated drinks and alcohol all slow gastric emptying independently; layering any of them onto Mounjaro's effect amplifies the discomfort. Plain, protein-led meals with modest carbohydrate and plenty of vegetables tend to be best tolerated. Staying well hydrated through the day (rather than catching up on fluids late at night) also supports the gut during this adjustment period.
One thing worth knowing about hydration: if vomiting has been frequent enough that you're struggling to keep fluids down, that's the point to contact your prescriber the same day rather than waiting for your next scheduled check-in. Dehydration from persistent GI symptoms can become a clinical concern, and your prescriber may want to review your dose or offer additional support. You can find a broader overview of Mounjaro side effects on our main side-effects page, which covers the full picture across the treatment period, not just the early weeks.
If you're supplementing with B12 alongside treatment, some people notice it influences how they feel too; our page on tirzepatide taken with B12 covers what's known there. And if you're earlier in your research and want a full grounding in what Mounjaro is and how it works, that's a good place to start.
Most nausea on Mounjaro is unpleasant but manageable. The signs that warrant prompt contact with your prescriber are different in character: vomiting that lasts more than a day or two, being unable to keep any food or fluid down, or severe stomach pain, particularly pain that radiates through to the back. That last symptom can indicate pancreatitis, a known but uncommon risk with GLP-1 medicines; the MHRA highlighted this in a Drug Safety Update published in January 2026, advising patients to seek urgent medical help for persistent severe abdominal pain of this kind.
Gallbladder symptoms (pain in the upper right abdomen, sometimes after eating) are also reported with this class of medicines and should be assessed by a doctor. These are not reasons to be frightened of the treatment; they are reasons to know the difference between normal adaptation and something that needs attention.
Any suspected side effect can be reported directly to the MHRA via the Yellow Card scheme, which exists precisely to capture real-world experience with medicines like this. If you've read this far and you're wondering whether tirzepatide is appropriate for you, or you're already on treatment and your symptoms feel hard to manage alone, start a free consultation with our prescribers, a real clinician reviews your details, not an automated system, and aftercare support is available seven days a week.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.